TELADOC HEALTH, INC.

(TDOC)
  Report
Real-time Estimate Cboe BZX  -  05/26 11:40:45 am EDT
33.37 USD   +5.39%
10:39aGoldman Sachs Adjusts Price Target for Teladoc to $55 From $77, Keeps Buy Rating
MT
05/13Piper Sandler Adjusts Teladoc Price Target to $42 From $41, Maintains Overweight Rating
MT
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on TELADOC HEALTH, INC.
10:39aGoldman Sachs Adjusts Price Target for Teladoc to $55 From $77, Keeps Buy Rating
MT
05/13Piper Sandler Adjusts Teladoc Price Target to $42 From $41, Maintains Overweight Rating
MT
05/05Argus Research Downgrades Teladoc to Hold from Buy
MT
04/28Needham Adjusts Teladoc's Price Target to $48 from $100, Keeps Buy Rating
MT
04/28Stifel Lowers Teladoc's Price Target to $45 From $74, Maintains Hold Rating
MT
04/28SVB Leerink Downgrades Teladoc to Market Perform From Outperform, Cuts Price Target to ..
MT
04/28Goldman Sachs Lowers Price Target for Teladoc to $77 From $113, Maintains Buy Rating
MT
04/28JPMorgan Downgrades Teladoc to Neutral From Overweight, Lowers PT to $53 From $125
MT
04/28Deutsche Bank Adjusts Teladoc Price Target to $44 From $78, Maintains Hold Rating
MT
04/28Credit Suisse Downgrades Teladoc to Neutral from Outperform, Says Q1 Results In-Line Bu..
MT
04/28Baird Adjusts Teladoc's Price Target to $38 From $64, Maintains Neutral Rating
MT
04/28RBC Slashes Price Target on Teladoc to $65 From $120 After Guidance Cut, Maintains Outp..
MT
04/28Wells Fargo Downgrades Teladoc to Equalweight From Overweight; Price Target is $40
MT
04/28Citigroup Downgrades Teladoc to Neutral From Buy
MT
04/28Guggenheim Downgrades Teladoc to Neutral From Buy
MT
04/28William Blair Downgrades Teladoc to Market Perform From Outperform
MT
04/12RBC Slashes Price Target on Teladoc to $120 From $215, Maintains Outperform Rating
MT
04/07Guggenheim Starts Teladoc at Buy With $96 Price Target
MT
03/21Goldman Sachs Cuts Teladoc's Price Target to $113 From $120, Maintains Buy Rating
MT
03/08UBS Adjusts Teladoc Price Target to $72 From $130, Maintains Neutral Rating
MT
03/08Piper Sandler Adjusts Teladoc's Price Target to $104 From $108, Reiterates Overweight R..
MT
03/03Argus Research Upgrades Teladoc to Buy From Hold; Price Target is $95
MT
02/25Credit Suisse Trims Teladoc's Price Target to $114 from $151, Updates Model for New Rep..
MT
02/24Deutsche Bank Adjusts Teladoc's Price Target to $78 From $81, Maintains Hold Rating
MT
02/23Stifel Nicolaus Adjusts Teladoc Price Target to $74 From $83, Maintains Hold Rating
MT
02/23Stephens Adjusts Teladoc's Price Target to $60 From $90, Keeps Equalweight Rating
MT
02/23Oppenheimer Adjusts Teladoc's Price Target to $130 From $160, Maintains Outperform Rati..
MT
02/23Craig-Hallum Adjusts Teladoc's Price Target to $67 From $82, Reiterates Hold Rating
MT
02/23Needham Adjusts Teladoc's Price Target to $100 From $170, Maintains Buy Rating
MT
02/23Baird Adjusts Teladoc's Price Target to $72 From $110, Maintains Neutral Rating
MT
02/23JPMorgan Adjusts Teladoc's Price Target to $125 From $208, Reiterates Overweight Rating
MT
02/23Barclays Adjusts Teladoc's Price Target to $77 From $95, Keeps Equalweight Rating
MT
02/23SVB Leerink Adjusts Teladoc's Price Target to $161 From $193, Keeps Outperform Rating
MT
02/23KeyBanc Adjusts Teladoc's Price Target to $100 From $180, Reiterates Overweight Rating
MT
02/11Goldman Sachs Initiates Teladoc at Buy with $121 Price Target
MT
02/08Piper Sandler Adjusts Teladoc's Price Target to $108 From $118, Reiterates Overweight R..
MT
02/07Jefferies Adjusts Teladoc's Price Target to $82 From $113, Reiterates Hold Rating
MT
01/25Deutsche Bank Adjusts Teladoc's Price Target to $81 From $163, Maintains Hold Rating
MT
01/19Oppenheimer Adjusts Teladoc's Price Target to $160 From $185, Maintains Outperform Rati..
MT
01/19Berenberg Bank Assumes Coverage on Teladoc With Buy Rating, $141 Price Target
MT
01/18Barclays Adjusts Teladoc's Price Target to $95 From $150, Maintains Equalweight Rating
MT
01/11Piper Sandler Adjusts Teladoc's Price Target to $118 From $183, Reiterates Overweight R..
MT
01/07Credit Suisse Lowers Teladoc's PT to $151 from $207, Says Investors Concerned with Lack..
MT
2021Berenberg Bank Suspends Coverage of Accolade, American Well Corp., Health Catalyst, Omn..
MT
2021Canaccord Genuity Adjusts Teladoc PT to $160 From $188, Maintains Buy Rating
MT
2021Wells Fargo Adjusts Teladoc's Price Target to $162 From $165, Reiterates Overweight Rat..
MT
2021Stifel Nicolaus Adjusts Teladoc PT to $135 From $153, Maintains Hold Rating
MT
2021BTIG Downgrades Teladoc to Neutral From Buy
MT
2021Oppenheimer Adjusts Teladoc PT to $185 From $200, Maintains Outperform Rating
MT
2021Credit Suisse Lowers Teladoc Health's PT to $207 from $208; Keeps Outperform Rating
MT
2021SVB Leerink Adjusts Teladoc's Price Target to $193 from $205, Keeps Outperform Rating
MT
2021Stephens Adjusts Price Target on Teladoc to $135 From $140, Keeps Equal-Weight Rating
MT
2021Citigroup Adjusts Teladoc's Price Target to $175 From $190, Reiterates Buy Rating
MT
2021Teladoc Price Target From RBC Cut to $215 From $260 as Firm Notes Investor Concerns But..
MT
2021JPMorgan Adjusts Teladoc's Price Target to $208 From $270, Maintains Overweight Rating
MT
2021Wells Fargo Adjusts Price Target on Teladoc to $165 From $156, Maintains Overweight Rat..
MT
2021Deutsche Bank Adjusts Teladoc PT to $163 From $153, Maintains Hold Rating
MT
2021Craig-Hallum Adjusts Teladoc's Price Target to $150 From $165, Reiterates Hold Rating
MT
2021Oppenheimer Adjusts Teladoc PT to $200 From $220, Maintains Outperform Rating
MT
2021Canaccord Genuity Adjusts Teladoc's Price Target to $188 From $236, Reiterates Buy Rati..
MT
2021UBS Lowers Teladoc's Price Target to $135 From $142 on Margin Expectations; Neutral Rat..
MT
2021Needham Adjusts Teladoc's Price Target to $170 From $205, Reiterates Buy Rating
MT
2021Barclays Adjusts Teladoc's Price Target to $150 From $170, Keeps Equal-Weight Rating
MT
2021SVB Leerink Adjusts Teladoc's Price Target to $205 from $218, Keeps Outperform Rating
MT
2021Piper Sandler Adjusts Teladoc's Price Target to $183 From $291, Reiterates Overweight R..
MT
2021Berenberg Bank Adjusts Teladoc PT to $204 From $230, Maintains Buy Rating
MT
2021Citigroup Adjusts Teladoc's Price Target to $190 From $225, Reiterates Buy Rating
MT
2021TELADOC HEALTH : Wells Fargo Starts Teladoc at Overweight With $156 Price Target
MT
2021TELADOC HEALTH : Berenberg Bank Adjusts Teladoc PT to $230 From $227, Maintains Buy Rating
MT
2021TELADOC HEALTH : Cowen Adjusts Teladoc's Price Target to $188 From $240, Keeps Outperform ..
MT
2021TELADOC HEALTH : Berenberg Bank Adjusts Teladoc PT to $227 From $252, Maintains Buy Rating
MT
2021TELADOC HEALTH : Argus Downgrades Teladoc to Hold From Buy
MT
2021TELADOC HEALTH : UBS Adjusts Teladoc's PT to $142 From $163, Citing Lower Chronic Care Mem..
MT
2021TELADOC HEALTH : Oppenheimer Adjusts Teladoc PT to $220 From $250, Maintains Outperform Ra..
MT
2021TELADOC HEALTH : Deutsche Bank Downgrades Teladoc to Hold from Buy, Adjusts Price Target t..
MT
1  2Next
Upcoming event on TELADOC HEALTH, INC.